Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Spotlight on Hadassah's Dr. Yuval Gielchinsky: Specialist in Fetal Medicine


Dr. Yuval Gielchinsky

Dr. Yuval Gielchinsky, an obstetrician with a PhD in molecular biology, is a specialist in Fetal Medicine at the Hadassah University Medical Center, who honed his knowledge and skills during a two-and-half-year fellowship with the founder of the first Fetal Medicine Unit in the United Kingdom at King's College in London, Prof. Kypros Nicolaides.

Now back at Hadassah, Dr. Gielchinsky has begun establishing a Fetal Medicine Unit at the Medical Center. Unlike the current practice of regarding maternal and fetal medicine as a single entity, this relatively new multidisciplinary field of fetal medicine focuses solely on the baby in the womb, Dr. Gielchinsky explains.

Dr. Gielchinsky has already altered conventional screening strategies, instituting first trimester screening--involving ultrasound and chromosome identification--to identify problems and anomalies during the 12th week of growth. He has introduced endoscopic examination of the womb to provide additional information on the baby's condition. If the endoscopy reveals a problem, he can then intervene, as appropriate. Operating on a fetus in the womb, Dr. Gielchinsky is able to correct developmental abnormalities, ensuring, for example, that twins each have an individual source of blood.

Before he left for London, Dr. Gielchinsky was the Principle Investigator of the Hadassah-Hebrew University research team which made the groundbreaking discovery that pregnancy restores liver regeneration in aged mice. The implications of this finding created international interest since the discovery could eventually be relevant to other tissues and organs and lead to the ability to stimulate their regeneration.

Dr. Gielchinsky believes that "Hadassah is strong enough to set the example" and can lead the way in creating new policies in Israel for better care of babies while still in the womb.

Date: 9/12/2011


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America